Clinical Trial Update: Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating combination chemotherapy with or without topotecan for newly diagnosed localized Ewing sarcoma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: Children's Oncology Group | Conditions: Sarcoma | Phase 3 | Status: WITHDRAWN